Cover image of the article: Successful Treatment of Congenital Chyloperitoneum with Platelet-Rich Fibrin Glue

Image Credit:Inn J Pediatr

Successful Treatment of Congenital Chyloperitoneum with Platelet-Rich Fibrin Glue

Authors

Marjan Joudi1, Daryoush Hamidi Alamdari2,*, Hamid-Reza Rahimi3
*Corresponding Author: Email: hamidiad@mums.ac.ir

Innovative Journal of Pediatrics:Vol. 23, issue 3; 357-359
Published online:Dec 28, 2012
Article type:Case Report
Received:Nov 24, 2011
Accepted:Jul 23, 2012
How to Cite:Joudi M, Hamidi Alamdari D, Rahimi H. Successful Treatment of Congenital Chyloperitoneum with Platelet-Rich Fibrin Glue. Inn J Pediatr. 2013;23(3):. doi:

Abstract

Background: Congenital chyloperitoneum is an uncommon clinical condition. A few cases of congenital chyloperitoneum in children have been described who were treated in a variety of methods.
Case Presentation: Congenital chyloperito was diagnosed in a 5-day-old baby boy with a significant abdominal distension. Due to the failed conservative managements by medium-chain triglycerides (MCT) enriched milk and partial parenteral nutrition (PPN), the authors tried platelet rich fibrin glue (PRFG) as an alternative choice which was applied through an already inserted intra-abdominal catheter. PRFG successfully stopped the lymph leakage from all over the small intestinal mesentery;  thereby PRFG may be considered as an effective alternative treatment before surgical intervention.
Conclusion: Applying PRFG is an easy, safe, and effective alternative option that may be used to close the chylous ascites lymph leakage in children if conservative management with PPN fails.

 

Highlights

References

  • 1.
    References are available on the PDF.

Copyright

© 2013, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

11
Oct
2020
Treatment of Congenital Chylothorax Using High-Dose Octreotide

Treatment of Congenital Chylothorax Using High-Dose Octreotide

Jinkyung Seo,
Sook Kyung Yum

Seo J, Yum SK. Treatment of Congenital Chylothorax Using High-Dose Octreotide. Inn J Pediatr. 2021;31(1):e107155. doi: https://doi.org/10.5812/ijp.107155

3
Feb
2011
Chylothorax secondary to Obstruction of the Superior Vena Cava: A late Complication of the Atrial Septal Defect Repair

Chylothorax secondary to Obstruction of the Superior Vena Cava: A late Complication of the Atrial Septal Defect Repair

Asadollah Mirzai

Mirzai A. Chylothorax secondary to Obstruction of the Superior Vena Cava: A late Complication of the Atrial Septal Defect Repair. Multidiscip Cardio Annal. 2011;3(1):e8737. doi:

31
Dec
2009
Retroperitoneoscopic Management of Chyluria: Our Experience

Retroperitoneoscopic Management of Chyluria: Our Experience

Biswajit Datta,
Uday Shankar Dwivedi,
Sameer Trivedi,
Mojjada Prasad Rao,
Pratap Bahadur Singh

Datta B, Dwivedi U, Trivedi S, Rao M, Singh P. Retroperitoneoscopic Management of Chyluria: Our Experience. Nephro-Urol Mon. 2009;1(2):. doi:

30
Jun
2009
Chyluria - An Overview

Chyluria - An Overview

Sachit Sharma,
Ashok Kumar Hemal

Sharma S, Hemal A. Chyluria - An Overview. Nephro-Urol Mon. 2009;1(1):. doi:

31
Aug
2017
Early Chylothorax After Coronary Artery Bypass Grafting

Early Chylothorax After Coronary Artery Bypass Grafting

Feridoun Sabzi,
Reza Faraji

Sabzi F, Faraji R. Early Chylothorax After Coronary Artery Bypass Grafting. Zahedan J Res Med Sci. 2017;19(8):e9067. doi: https://doi.org/10.5812/zjrms.9067

More by these authors

Marjan JoudiPubMedScholar
Daryoush Hamidi AlamdariPubMedScholar
Hamid-Reza RahimiPubMedScholar
Share
Cited by
Metrics